Study Shows Radial Access Is Less Expensive than Femoral Access for PCI
Transradial percutaneous coronary intervention (PCI) is significantly less expensive than transfemoral PCI from the hospital perspective, as procedural costs for the two access routes are similar, but transradial PCI is associated with lower bleeding rates and a shorter length of stay, which reduces associated costs, according to a study published in JACC: Cardiovascular Interventions.
"For hospitals performing 1,000 PCI procedures annually, a 10 percent to 20 percent transradial adoption rate would imply incremental savings of $80,000 to $160,000 per year," said lead author Amit Amin, MD, MSc, Washington University School of Medicine, St. Louis. "As hospitals increasingly use same-day discharge protocols for transradial access patients, length of stay will decrease and cost savings attributable to transradial access will likely increase further."
These cost implications will grow in importance as reimbursement models evolve, Dr. Amin adds. Current fee-for-service models typically pay a flat reimbursement for PCI regardless of the access route. As per-episode bundled payment models become more prevalent, comparative costs at the hospital level will become a more important factor in selecting between treatment options that offer similar clinical outcomes.
< Back to Listings